Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.
A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results